🌐 Entity
Psoriasis
Autoimmune diseases of the skin
📊 Rating
3 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Pharmaceutical innovation (2)
- Medical Innovation (1)
- Patient Care (1)
- Treatment Accessibility (1)
- Treatment efficacy (1)
- Market impact (1)
- Combination therapy (1)
- Chronic disease treatment (1)
🏷️ Keywords
Psoriasis (3) · Taltz (2) · Zepbound (2) · Eli Lilly (2) · Combination therapy (2) · ICOTYDE (1) · Oral medication (1) · Injectables (1) · Dermatology (1) · Immune system (1) · Treatment options (1) · Clinical trial (1) · Biologic treatment (1) · Pharmaceutical economy (1) · Weight loss (1) · Clinical study (1) · Pharmaceutical innovation (1)
📖 Key Information
Psoriasis is a long-lasting, noncontagious autoimmune disease characterized by patches of abnormal skin. These areas are red, pink, or purple, dry, itchy, and scaly. Psoriasis varies in severity from small localized patches to complete body coverage.
📰 Related News (3)
-
🇺🇸 The First Psoriasis Pill That Could Rival Injectables Is Here
A closer look at ICOTYDE, including how it works and who it’s for....
-
-
🇺🇸 Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study
Eli Lilly said on Wednesday the combined use of its weight-loss drug Zepbound with psoriasis treatment Taltz showed better results in a late-stage st...
🔗 Entity Intersection Graph
People and organizations frequently mentioned alongside Psoriasis:
-
Eli Lilly · 2 shared articles -
🌐
Ixekizumab · 2 shared articles
-
Tirzepatide · 2 shared articles -
🌐
Combination therapy · 1 shared articles
-
Injection (medicine) · 1 shared articles -
Route of administration · 1 shared articles -
🌐
Dermatology · 1 shared articles
-
Weight loss · 1 shared articles